Search Results - "Lahtela, J"

Refine Results
  1. 1

    Self-reported non-severe hypoglycaemic events in Europe by Östenson, C. G., Geelhoed-Duijvestijn, P., Lahtela, J., Weitgasser, R., Markert Jensen, M., Pedersen-Bjergaard, U.

    Published in Diabetic medicine (01-01-2014)
    “…Aims Hypoglycaemia presents a barrier to optimum diabetes management but data are limited on the frequency of hypoglycaemia incidents outside of clinical…”
    Get full text
    Journal Article
  2. 2

    Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial by Ahmann, A., Rodbard, H. W., Rosenstock, J., Lahtela, J. T., de Loredo, L., Tornøe, K., Boopalan, A., Nauck, M. A.

    Published in Diabetes, obesity & metabolism (01-11-2015)
    “…Aim To confirm the superiority, compared with placebo, of adding liraglutide to pre‐existing basal insulin analogue ± metformin in adults with inadequately…”
    Get full text
    Journal Article
  3. 3

    Infrared Thermography Compared to Standard Care in the Prevention and Care of Diabetic Foot: A Cost Analysis Utilizing Real-World Data and an Expert Panel by Kurkela, Olli, Lahtela, Jorma, Arffman, Martti, Forma, Leena

    Published in ClinicoEconomics and outcomes research (01-01-2023)
    “…Infrared thermography (IRT) is a non-invasive technology for screening and early detection of diabetic foot. Real-world data and the Delphi technique were used…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Charcot Arthropathy of the Diabetic Foot. Current Concepts and Review of 36 Cases by Pakarinen, T.-K., Laine, H.-J., Honkonen, S. E., Peltonen, J., Oksala, H., Lahtela, J.

    Published in Scandinavian journal of surgery (2002)
    “…Background and Aims: The incidence of diabetic Charcot neuroarthropathy has increased. The purpose here was to study the current diagnostics and treatment of…”
    Get full text
    Journal Article
  9. 9

    P292 Efficacité et tolérance de l’adjonction du liraglutide à une insuline basale en comparaison au placebo chez des patients diabétiques de type 2 (résultats de l’essai randomisé contrôlé LIRA-ADD2BASAL) by Bouzidi, A, Lahtela, J, Ahmann, A, Rodbard, H, De Loredo, L, Tornøe E, K, Boopalan, A, Nauck, M

    Published in Diabetes & metabolism (01-03-2015)
    “…Objectif Établir la supériorité de l’efficacité du liraglutide (LIRA) et sa bonne tolérance sur le placebo (PLAC) en ajout d’un traitement par insuline basale…”
    Get full text
    Journal Article
  10. 10

    Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report by LAHTELA, J. T, KNIP, M, PAUL, R, ANTONEN, J, SALMI, J

    Published in Diabetes care (01-01-1997)
    “…Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report. J T Lahtela , M Knip , R Paul , J…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients by NEVALAINEN, P, LAHTELA, J. T, MUSTONEN, J, PASTERNACK, A

    “…Intraperitoneally administered insulin is regarded as the most physiological replacement therapy, leading to lower peripheral insulin concentrations and equal…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Lethal evolution of a newborn with consistent features of hydrolethalus syndrome--Romanian patient by Belengeanu, V, Viskari, H, Tallila, J, Lahtela, J, Farcas, S, Andreescu, N, Stoian, M, Bohiltea, C L, Fryns, J P

    Published in Genetic counseling (01-01-2011)
    “…Hydrolethalus syndrome is a severe lethal disorder most commonly found in Finland. We present a lethal case of complex congenital malformation in a Romanian…”
    Get more information
    Journal Article
  16. 16

    (359) Single Cell Transcriptomic Analysis of Acute Heart Rejection in a Rat Model by Ainasoja, O., Bishwa, G., Lahtela, J., Syrjälä, S., Lemström, K., Hurskainen, M.

    “…Heart transplantation (tx) is the last treatment option for end-stage cardiac failure. Acute rejection is among the most common reasons for death after heart…”
    Get full text
    Journal Article
  17. 17

    Spatial Transcriptomic Analysis of Acute Heart Rejection Model by Ainasoja, O.H., Hurskainen, M., Ghimire, B., Lahtela, J., Syrjälä, S., Lemström, K.

    “…Heart transplantation (HTx) is sometimes the only treatment for end-stage cardiac disease, but survival after HTx is limited. Understanding the molecular…”
    Get full text
    Journal Article
  18. 18

    Hepatic subcapsular steatosis in diabetic CAPD patients treated with intraperitoneal insulin. Description of a typical pattern by Kallio, T, Nevalainen, P I, Lahtela, J T, Mustonen, J, Pasternack, A

    Published in Acta radiologica (1987) (01-05-2001)
    “…To describe a specific imaging pattern of hepatic fatty change typical of diabetic patients on continuous ambulatory peritoneal dialysis (CAPD) treated with…”
    Get more information
    Journal Article
  19. 19

    Natriuretic peptide and echocardiography after operation of atrial septal defect by Groundstroem, K.W.E., Iivainen, T.E., Lahtela, J.T., Talvensaari, T.J., Paakkala, T.A., Pasternack, A.I., Uusitalo, A.J.

    Published in International journal of cardiology (01-05-2003)
    “…Patients benefit from surgical seclusion of atrial septal defect but have excessive cardiovascular morbidity after the operation. We evaluated haemodynamics…”
    Get full text
    Journal Article
  20. 20